Injectables are a combination of dermal fillers and Botox used in facial aesthetic treatments, which help reduce wrinkles and play a crucial role in rejuvenating facial skin for smoother and younger look. These are injected under the skin or lips to plump up the tissues and gently lift it to restore collagen lost due to aging. Collagen and HA provide essential support to skin and help it retain its elasticity. The glabellar lines, wrinkles, and lines can be reduced with facial aesthetic treatment.
In terms of geographical regions, the Americas will be the major market contributor throughout the next few years. The US is the major revenue contributor in this region, where rapid advances in technology, the increasing awareness about aesthetic procedures, and the increasing demand for minimally invasive techniques, will bolster the market€™s growth prospects.
Market Analysis and Insights: Global Facial Injectables Market
The global Facial Injectables market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global Facial Injectables Scope and Segment
The global Facial Injectables market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Facial Injectables market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Botox
Dermal Fillers
Other
By the end users/application, this report covers the following segments
Hospitals
Clinics
Cosmetic Centers
Other
Competitive Landscape:
The report provides a list of all the key players in the Facial Injectables market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Facial Injectables key manufacturers in this market include:
Allergan
Merz Aesthetics
Prollenium Medical Technologies
Bloomega BioTechnology
Galderma
Ipsen Group
Suneva Medical
Polymekon
Visionmed
Syneron
Medytox
AQTIS Medical
ColBar LifeScience
SciVision Biotech
Hangzhou Techderm Biological Products
Qufu Guanglong Biochem
In terms of geographical regions, the Americas will be the major market contributor throughout the next few years. The US is the major revenue contributor in this region, where rapid advances in technology, the increasing awareness about aesthetic procedures, and the increasing demand for minimally invasive techniques, will bolster the market€™s growth prospects.
Market Analysis and Insights: Global Facial Injectables Market
The global Facial Injectables market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global Facial Injectables Scope and Segment
The global Facial Injectables market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Facial Injectables market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Botox
Dermal Fillers
Other
By the end users/application, this report covers the following segments
Hospitals
Clinics
Cosmetic Centers
Other
Competitive Landscape:
The report provides a list of all the key players in the Facial Injectables market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Facial Injectables key manufacturers in this market include:
Allergan
Merz Aesthetics
Prollenium Medical Technologies
Bloomega BioTechnology
Galderma
Ipsen Group
Suneva Medical
Polymekon
Visionmed
Syneron
Medytox
AQTIS Medical
ColBar LifeScience
SciVision Biotech
Hangzhou Techderm Biological Products
Qufu Guanglong Biochem
1 Facial Injectables Market Overview
1.1 Facial Injectables Product Overview
1.2 Facial Injectables Market Segment by Type
1.2.1 Botox
1.2.2 Dermal Fillers
1.2.3 Other
1.3 Global Facial Injectables Market Size by Type
1.3.1 Global Facial Injectables Market Size Overview by Type (2016-2027)
1.3.2 Global Facial Injectables Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Facial Injectables Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Facial Injectables Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Facial Injectables Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Facial Injectables Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Facial Injectables Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Facial Injectables Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Facial Injectables Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Facial Injectables Sales Breakdown by Type (2016-2021)
1.4.2 Europe Facial Injectables Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Facial Injectables Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Facial Injectables Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Facial Injectables Sales Breakdown by Type (2016-2021)
2 Global Facial Injectables Market Competition by Company
2.1 Global Top Players by Facial Injectables Sales (2016-2021)
2.2 Global Top Players by Facial Injectables Revenue (2016-2021)
2.3 Global Top Players Facial Injectables Price (2016-2021)
2.4 Global Top Manufacturers Facial Injectables Manufacturing Base Distribution, Sales Area, Product Type
2.5 Facial Injectables Market Competitive Situation and Trends
2.5.1 Facial Injectables Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Facial Injectables Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Facial Injectables as of 2020)
2.7 Date of Key Manufacturers Enter into Facial Injectables Market
2.8 Key Manufacturers Facial Injectables Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Facial Injectables Status and Outlook by Region
3.1 Global Facial Injectables Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Facial Injectables Historic Market Size by Region
3.2.1 Global Facial Injectables Sales in Volume by Region (2016-2021)
3.2.2 Global Facial Injectables Sales in Value by Region (2016-2021)
3.2.3 Global Facial Injectables Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Facial Injectables Forecasted Market Size by Region
3.3.1 Global Facial Injectables Sales in Volume by Region (2022-2027)
3.3.2 Global Facial Injectables Sales in Value by Region (2022-2027)
3.3.3 Global Facial Injectables Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Facial Injectables by Application
4.1 Facial Injectables Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Cosmetic Centers
4.1.4 Other
4.2 Global Facial Injectables Market Size by Application
4.2.1 Global Facial Injectables Market Size Overview by Application (2016-2027)
4.2.2 Global Facial Injectables Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Facial Injectables Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Facial Injectables Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Facial Injectables Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Facial Injectables Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Facial Injectables Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Facial Injectables Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Facial Injectables Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Facial Injectables Sales Breakdown by Application (2016-2021)
4.3.2 Europe Facial Injectables Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Facial Injectables Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Facial Injectables Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Facial Injectables Sales Breakdown by Application (2016-2021)
5 North America Facial Injectables by Country
5.1 North America Facial Injectables Historic Market Size by Country
5.1.1 North America Facial Injectables Sales in Volume by Country (2016-2021)
5.1.2 North America Facial Injectables Sales in Value by Country (2016-2021)
5.2 North America Facial Injectables Forecasted Market Size by Country
5.2.1 North America Facial Injectables Sales in Volume by Country (2022-2027)
5.2.2 North America Facial Injectables Sales in Value by Country (2022-2027)
6 Europe Facial Injectables by Country
6.1 Europe Facial Injectables Historic Market Size by Country
6.1.1 Europe Facial Injectables Sales in Volume by Country (2016-2021)
6.1.2 Europe Facial Injectables Sales in Value by Country (2016-2021)
6.2 Europe Facial Injectables Forecasted Market Size by Country
6.2.1 Europe Facial Injectables Sales in Volume by Country (2022-2027)
6.2.2 Europe Facial Injectables Sales in Value by Country (2022-2027)
7 Asia-Pacific Facial Injectables by Region
7.1 Asia-Pacific Facial Injectables Historic Market Size by Region
7.1.1 Asia-Pacific Facial Injectables Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Facial Injectables Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Facial Injectables Forecasted Market Size by Region
7.2.1 Asia-Pacific Facial Injectables Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Facial Injectables Sales in Value by Region (2022-2027)
8 Latin America Facial Injectables by Country
8.1 Latin America Facial Injectables Historic Market Size by Country
8.1.1 Latin America Facial Injectables Sales in Volume by Country (2016-2021)
8.1.2 Latin America Facial Injectables Sales in Value by Country (2016-2021)
8.2 Latin America Facial Injectables Forecasted Market Size by Country
8.2.1 Latin America Facial Injectables Sales in Volume by Country (2022-2027)
8.2.2 Latin America Facial Injectables Sales in Value by Country (2022-2027)
9 Middle East and Africa Facial Injectables by Country
9.1 Middle East and Africa Facial Injectables Historic Market Size by Country
9.1.1 Middle East and Africa Facial Injectables Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Facial Injectables Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Facial Injectables Forecasted Market Size by Country
9.2.1 Middle East and Africa Facial Injectables Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Facial Injectables Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Facial Injectables Business
10.1 Allergan
10.1.1 Allergan Corporation Information
10.1.2 Allergan Introduction and Business Overview
10.1.3 Allergan Facial Injectables Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Allergan Facial Injectables Products Offered
10.1.5 Allergan Recent Development
10.2 Merz Aesthetics
10.2.1 Merz Aesthetics Corporation Information
10.2.2 Merz Aesthetics Introduction and Business Overview
10.2.3 Merz Aesthetics Facial Injectables Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Allergan Facial Injectables Products Offered
10.2.5 Merz Aesthetics Recent Development
10.3 Prollenium Medical Technologies
10.3.1 Prollenium Medical Technologies Corporation Information
10.3.2 Prollenium Medical Technologies Introduction and Business Overview
10.3.3 Prollenium Medical Technologies Facial Injectables Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Prollenium Medical Technologies Facial Injectables Products Offered
10.3.5 Prollenium Medical Technologies Recent Development
10.4 Bloomega BioTechnology
10.4.1 Bloomega BioTechnology Corporation Information
10.4.2 Bloomega BioTechnology Introduction and Business Overview
10.4.3 Bloomega BioTechnology Facial Injectables Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Bloomega BioTechnology Facial Injectables Products Offered
10.4.5 Bloomega BioTechnology Recent Development
10.5 Galderma
10.5.1 Galderma Corporation Information
10.5.2 Galderma Introduction and Business Overview
10.5.3 Galderma Facial Injectables Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Galderma Facial Injectables Products Offered
10.5.5 Galderma Recent Development
10.6 Ipsen Group
10.6.1 Ipsen Group Corporation Information
10.6.2 Ipsen Group Introduction and Business Overview
10.6.3 Ipsen Group Facial Injectables Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Ipsen Group Facial Injectables Products Offered
10.6.5 Ipsen Group Recent Development
10.7 Suneva Medical
10.7.1 Suneva Medical Corporation Information
10.7.2 Suneva Medical Introduction and Business Overview
10.7.3 Suneva Medical Facial Injectables Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Suneva Medical Facial Injectables Products Offered
10.7.5 Suneva Medical Recent Development
10.8 Polymekon
10.8.1 Polymekon Corporation Information
10.8.2 Polymekon Introduction and Business Overview
10.8.3 Polymekon Facial Injectables Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Polymekon Facial Injectables Products Offered
10.8.5 Polymekon Recent Development
10.9 Visionmed
10.9.1 Visionmed Corporation Information
10.9.2 Visionmed Introduction and Business Overview
10.9.3 Visionmed Facial Injectables Sales, Revenue and Gross Margin (2016-2021)
10.9.4 Visionmed Facial Injectables Products Offered
10.9.5 Visionmed Recent Development
10.10 Syneron
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Facial Injectables Product Category, Application and Specification
10.10.3 Syneron Facial Injectables Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 Syneron Recent Development
10.11 Medytox
10.11.1 Medytox Corporation Information
10.11.2 Medytox Introduction and Business Overview
10.11.3 Medytox Facial Injectables Sales, Revenue and Gross Margin (2016-2021)
10.11.4 Medytox Facial Injectables Products Offered
10.11.5 Medytox Recent Development
10.12 AQTIS Medical
10.12.1 AQTIS Medical Corporation Information
10.12.2 AQTIS Medical Introduction and Business Overview
10.12.3 AQTIS Medical Facial Injectables Sales, Revenue and Gross Margin (2016-2021)
10.12.4 AQTIS Medical Facial Injectables Products Offered
10.12.5 AQTIS Medical Recent Development
10.13 ColBar LifeScience
10.13.1 ColBar LifeScience Corporation Information
10.13.2 ColBar LifeScience Introduction and Business Overview
10.13.3 ColBar LifeScience Facial Injectables Sales, Revenue and Gross Margin (2016-2021)
10.13.4 ColBar LifeScience Facial Injectables Products Offered
10.13.5 ColBar LifeScience Recent Development
10.14 SciVision Biotech
10.14.1 SciVision Biotech Corporation Information
10.14.2 SciVision Biotech Introduction and Business Overview
10.14.3 SciVision Biotech Facial Injectables Sales, Revenue and Gross Margin (2016-2021)
10.14.4 SciVision Biotech Facial Injectables Products Offered
10.14.5 SciVision Biotech Recent Development
10.15 Hangzhou Techderm Biological Products
10.15.1 Hangzhou Techderm Biological Products Corporation Information
10.15.2 Hangzhou Techderm Biological Products Introduction and Business Overview
10.15.3 Hangzhou Techderm Biological Products Facial Injectables Sales, Revenue and Gross Margin (2016-2021)
10.15.4 Hangzhou Techderm Biological Products Facial Injectables Products Offered
10.15.5 Hangzhou Techderm Biological Products Recent Development
10.16 Qufu Guanglong Biochem
10.16.1 Qufu Guanglong Biochem Corporation Information
10.16.2 Qufu Guanglong Biochem Introduction and Business Overview
10.16.3 Qufu Guanglong Biochem Facial Injectables Sales, Revenue and Gross Margin (2016-2021)
10.16.4 Qufu Guanglong Biochem Facial Injectables Products Offered
10.16.5 Qufu Guanglong Biochem Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Facial Injectables Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Facial Injectables Industrial Chain Analysis
11.4 Facial Injectables Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Facial Injectables Distributors
12.3 Facial Injectables Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Facial Injectables Product Overview
1.2 Facial Injectables Market Segment by Type
1.2.1 Botox
1.2.2 Dermal Fillers
1.2.3 Other
1.3 Global Facial Injectables Market Size by Type
1.3.1 Global Facial Injectables Market Size Overview by Type (2016-2027)
1.3.2 Global Facial Injectables Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Facial Injectables Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Facial Injectables Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Facial Injectables Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Facial Injectables Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Facial Injectables Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Facial Injectables Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Facial Injectables Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Facial Injectables Sales Breakdown by Type (2016-2021)
1.4.2 Europe Facial Injectables Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Facial Injectables Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Facial Injectables Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Facial Injectables Sales Breakdown by Type (2016-2021)
2 Global Facial Injectables Market Competition by Company
2.1 Global Top Players by Facial Injectables Sales (2016-2021)
2.2 Global Top Players by Facial Injectables Revenue (2016-2021)
2.3 Global Top Players Facial Injectables Price (2016-2021)
2.4 Global Top Manufacturers Facial Injectables Manufacturing Base Distribution, Sales Area, Product Type
2.5 Facial Injectables Market Competitive Situation and Trends
2.5.1 Facial Injectables Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Facial Injectables Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Facial Injectables as of 2020)
2.7 Date of Key Manufacturers Enter into Facial Injectables Market
2.8 Key Manufacturers Facial Injectables Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Facial Injectables Status and Outlook by Region
3.1 Global Facial Injectables Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Facial Injectables Historic Market Size by Region
3.2.1 Global Facial Injectables Sales in Volume by Region (2016-2021)
3.2.2 Global Facial Injectables Sales in Value by Region (2016-2021)
3.2.3 Global Facial Injectables Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Facial Injectables Forecasted Market Size by Region
3.3.1 Global Facial Injectables Sales in Volume by Region (2022-2027)
3.3.2 Global Facial Injectables Sales in Value by Region (2022-2027)
3.3.3 Global Facial Injectables Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Facial Injectables by Application
4.1 Facial Injectables Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Cosmetic Centers
4.1.4 Other
4.2 Global Facial Injectables Market Size by Application
4.2.1 Global Facial Injectables Market Size Overview by Application (2016-2027)
4.2.2 Global Facial Injectables Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Facial Injectables Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Facial Injectables Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Facial Injectables Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Facial Injectables Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Facial Injectables Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Facial Injectables Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Facial Injectables Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Facial Injectables Sales Breakdown by Application (2016-2021)
4.3.2 Europe Facial Injectables Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Facial Injectables Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Facial Injectables Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Facial Injectables Sales Breakdown by Application (2016-2021)
5 North America Facial Injectables by Country
5.1 North America Facial Injectables Historic Market Size by Country
5.1.1 North America Facial Injectables Sales in Volume by Country (2016-2021)
5.1.2 North America Facial Injectables Sales in Value by Country (2016-2021)
5.2 North America Facial Injectables Forecasted Market Size by Country
5.2.1 North America Facial Injectables Sales in Volume by Country (2022-2027)
5.2.2 North America Facial Injectables Sales in Value by Country (2022-2027)
6 Europe Facial Injectables by Country
6.1 Europe Facial Injectables Historic Market Size by Country
6.1.1 Europe Facial Injectables Sales in Volume by Country (2016-2021)
6.1.2 Europe Facial Injectables Sales in Value by Country (2016-2021)
6.2 Europe Facial Injectables Forecasted Market Size by Country
6.2.1 Europe Facial Injectables Sales in Volume by Country (2022-2027)
6.2.2 Europe Facial Injectables Sales in Value by Country (2022-2027)
7 Asia-Pacific Facial Injectables by Region
7.1 Asia-Pacific Facial Injectables Historic Market Size by Region
7.1.1 Asia-Pacific Facial Injectables Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Facial Injectables Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Facial Injectables Forecasted Market Size by Region
7.2.1 Asia-Pacific Facial Injectables Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Facial Injectables Sales in Value by Region (2022-2027)
8 Latin America Facial Injectables by Country
8.1 Latin America Facial Injectables Historic Market Size by Country
8.1.1 Latin America Facial Injectables Sales in Volume by Country (2016-2021)
8.1.2 Latin America Facial Injectables Sales in Value by Country (2016-2021)
8.2 Latin America Facial Injectables Forecasted Market Size by Country
8.2.1 Latin America Facial Injectables Sales in Volume by Country (2022-2027)
8.2.2 Latin America Facial Injectables Sales in Value by Country (2022-2027)
9 Middle East and Africa Facial Injectables by Country
9.1 Middle East and Africa Facial Injectables Historic Market Size by Country
9.1.1 Middle East and Africa Facial Injectables Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Facial Injectables Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Facial Injectables Forecasted Market Size by Country
9.2.1 Middle East and Africa Facial Injectables Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Facial Injectables Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Facial Injectables Business
10.1 Allergan
10.1.1 Allergan Corporation Information
10.1.2 Allergan Introduction and Business Overview
10.1.3 Allergan Facial Injectables Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Allergan Facial Injectables Products Offered
10.1.5 Allergan Recent Development
10.2 Merz Aesthetics
10.2.1 Merz Aesthetics Corporation Information
10.2.2 Merz Aesthetics Introduction and Business Overview
10.2.3 Merz Aesthetics Facial Injectables Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Allergan Facial Injectables Products Offered
10.2.5 Merz Aesthetics Recent Development
10.3 Prollenium Medical Technologies
10.3.1 Prollenium Medical Technologies Corporation Information
10.3.2 Prollenium Medical Technologies Introduction and Business Overview
10.3.3 Prollenium Medical Technologies Facial Injectables Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Prollenium Medical Technologies Facial Injectables Products Offered
10.3.5 Prollenium Medical Technologies Recent Development
10.4 Bloomega BioTechnology
10.4.1 Bloomega BioTechnology Corporation Information
10.4.2 Bloomega BioTechnology Introduction and Business Overview
10.4.3 Bloomega BioTechnology Facial Injectables Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Bloomega BioTechnology Facial Injectables Products Offered
10.4.5 Bloomega BioTechnology Recent Development
10.5 Galderma
10.5.1 Galderma Corporation Information
10.5.2 Galderma Introduction and Business Overview
10.5.3 Galderma Facial Injectables Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Galderma Facial Injectables Products Offered
10.5.5 Galderma Recent Development
10.6 Ipsen Group
10.6.1 Ipsen Group Corporation Information
10.6.2 Ipsen Group Introduction and Business Overview
10.6.3 Ipsen Group Facial Injectables Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Ipsen Group Facial Injectables Products Offered
10.6.5 Ipsen Group Recent Development
10.7 Suneva Medical
10.7.1 Suneva Medical Corporation Information
10.7.2 Suneva Medical Introduction and Business Overview
10.7.3 Suneva Medical Facial Injectables Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Suneva Medical Facial Injectables Products Offered
10.7.5 Suneva Medical Recent Development
10.8 Polymekon
10.8.1 Polymekon Corporation Information
10.8.2 Polymekon Introduction and Business Overview
10.8.3 Polymekon Facial Injectables Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Polymekon Facial Injectables Products Offered
10.8.5 Polymekon Recent Development
10.9 Visionmed
10.9.1 Visionmed Corporation Information
10.9.2 Visionmed Introduction and Business Overview
10.9.3 Visionmed Facial Injectables Sales, Revenue and Gross Margin (2016-2021)
10.9.4 Visionmed Facial Injectables Products Offered
10.9.5 Visionmed Recent Development
10.10 Syneron
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Facial Injectables Product Category, Application and Specification
10.10.3 Syneron Facial Injectables Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 Syneron Recent Development
10.11 Medytox
10.11.1 Medytox Corporation Information
10.11.2 Medytox Introduction and Business Overview
10.11.3 Medytox Facial Injectables Sales, Revenue and Gross Margin (2016-2021)
10.11.4 Medytox Facial Injectables Products Offered
10.11.5 Medytox Recent Development
10.12 AQTIS Medical
10.12.1 AQTIS Medical Corporation Information
10.12.2 AQTIS Medical Introduction and Business Overview
10.12.3 AQTIS Medical Facial Injectables Sales, Revenue and Gross Margin (2016-2021)
10.12.4 AQTIS Medical Facial Injectables Products Offered
10.12.5 AQTIS Medical Recent Development
10.13 ColBar LifeScience
10.13.1 ColBar LifeScience Corporation Information
10.13.2 ColBar LifeScience Introduction and Business Overview
10.13.3 ColBar LifeScience Facial Injectables Sales, Revenue and Gross Margin (2016-2021)
10.13.4 ColBar LifeScience Facial Injectables Products Offered
10.13.5 ColBar LifeScience Recent Development
10.14 SciVision Biotech
10.14.1 SciVision Biotech Corporation Information
10.14.2 SciVision Biotech Introduction and Business Overview
10.14.3 SciVision Biotech Facial Injectables Sales, Revenue and Gross Margin (2016-2021)
10.14.4 SciVision Biotech Facial Injectables Products Offered
10.14.5 SciVision Biotech Recent Development
10.15 Hangzhou Techderm Biological Products
10.15.1 Hangzhou Techderm Biological Products Corporation Information
10.15.2 Hangzhou Techderm Biological Products Introduction and Business Overview
10.15.3 Hangzhou Techderm Biological Products Facial Injectables Sales, Revenue and Gross Margin (2016-2021)
10.15.4 Hangzhou Techderm Biological Products Facial Injectables Products Offered
10.15.5 Hangzhou Techderm Biological Products Recent Development
10.16 Qufu Guanglong Biochem
10.16.1 Qufu Guanglong Biochem Corporation Information
10.16.2 Qufu Guanglong Biochem Introduction and Business Overview
10.16.3 Qufu Guanglong Biochem Facial Injectables Sales, Revenue and Gross Margin (2016-2021)
10.16.4 Qufu Guanglong Biochem Facial Injectables Products Offered
10.16.5 Qufu Guanglong Biochem Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Facial Injectables Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Facial Injectables Industrial Chain Analysis
11.4 Facial Injectables Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Facial Injectables Distributors
12.3 Facial Injectables Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
